Kolon Pharmaceutical: Subsidiary's Injection of Biperiden/Sodium Chloride Injection Solution Obtains Drug Registration Approval.

Korun Pharmaceuticals announced that its subsidiary Hunan Korun Pharmaceutical Co., Ltd.'s chemical drug "Imipenem/Cilastatin Sodium Injection" has obtained drug registration approval from the National Medical Products Administration. This drug is the first domestically approved powder-liquid dual chamber bag packaging form, with wide antibacterial spectrum, stable against -lactamases, strong antibacterial activity, and lower renal and central nervous system toxicity.